Michel Lagarde, Director of Vertex Pharmaceuticals VRTX, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $51.3M. The latest trade was on 05/01.

ML

ML

Michel Lagarde

Director

Company

Vertex Pharmaceuticals VRTX

First filing

23/02/24

Trades

54 trades

Buys / sales

0 / 6

12-month net buying

−$51.3M

Last trade

05/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Thermo Fisher ScientificTMO	Open-market sale	25/12/04	25/12/05	22,046 sh	$563.56	$12,424,243.76	−20.8%
Thermo Fisher ScientificTMO	Open-market sale	25/12/02–25/12/03	25/12/04	62,000 sh3 trades	$582.68avg.	$36,126,126.38	−48.6%
Thermo Fisher ScientificTMO	Open-market sale	25/11/13	25/11/14	4,638 sh	$594.42	$2,756,919.96	−16.5%
Thermo Fisher ScientificTMO	Open-market sale	24/05/14	24/05/15	20,000 sh	$590.05	$11,801,000	−52.4%